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Abstract 
Objective: The seeds of Nigella sativa locally known as "Kalonji" has been used in traditional 
medicine for the treatment of a variety of diseases including diarrhoea and asthma. The crude extract 
of N. sativa seeds (Ns.Cr) was studied in vitro for its possible spasmolytic and bronchodilator 
activities to rationalize the folkloric uses. 
Methods: Isolated rabbit jejunum and guinea-pig tracheal preparations were set up in Tyrode's and Kreb's 
solutions respectively and aerated with 5% CO2 
 in oxygen. Isotonic and isometric responses were measured on 
Bioscience oscillograph and Grass polygraph respectively. 
Results: The Ns.Cr caused a dose-dependent (0.1 - 3.0 mg/ml) relaxation of spontaneous contractions in rabbit 
jejunum. Ns.Cr also inhibited K+-induced contractions in a similar dose range, suggestive of calcium channel 
blockade (CCB). This effect was confirmed when pretreatment of the tissue with Ns.Cr, produced a dose-
dependent shift in the Ca++ dose-response curves to the right similar to that of verapamil, a standard calcium 
channel blocker. In guinea-pig trachea, it caused relaxation of carbachol-, histamine- or K+-induced contractions 
indicating CCB. Activity-directed fractionation revealed that the CCB activity is concentrated in the petroleum 
ether fraction, which was found to be approximately 10 times more potent than the crude extract both in jejunum 
and tracheal preparations. 
Conclusion: These data indicate that the crude extract of Nigella sativa seeds exhibits spasmolytic and 
bronchodilator activities mediated possibly through calcium channel blockade and this activity is concentrated in 
the organic fraction. Its usefulness for diarrhoea and asthma in traditional medicine, appears thus to be based 
on a sound mechanistic background (JPMA 51:115;2001). 
Introduction 
Nigel la sativa 
	 Linn. 
	 belongs to 	 family 
Ranunculaceae. The herb is widely grown in different parts 
of the world and its seeds are used as condiment. In south 
Asia it is known as "Kalonji" and its Arabic name is "Habat-
ul Sauda"1
. In the Western world, it is known as "Black 
cumin"2
. In the traditional system of medicine, it is 
recommended in a wide range of ailments including, 
asthma, chronic headache, migraine, chest congestion, 
dysmenorrhoea, infections (both fungal and bacterial), 
obesity, paralysis, hemiplegia, back pain, rheumatism, 
hypertension and GI problems, like dyspepsia, flatulence 
and diarrhoea1.3. It has also been used as stimulant, diuretic, 
emmenagogue, lactagogue and anthelmintic. Its use in 
asthma and eczema has also been recognized worldwide4. 
Phytochemical studies on seeds revealed the 
presence of volatile oil (1.5%), fixed oil (37.5%) nigellin, 
melanthin and arabic acid', and thimoquinone5. The volatile 
oil consists mainly of carvone (45-60%), carvene and 
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 and thymoquinone6. Pharmacological effects of 
the isolated alkaloids from N. sativa seeds viz. nigellidine, 
nigellimine and nigellicine have not been reported.7-9 
The popularity of the plant was highly enhanced by 
the ideological belief in the herb as a cure for multiple 
diseases. In fact, this plant has occupied special place for its 
wide range of medicinal value in the Islamic civilizations. 
Due to the sayings of Holy Prophet, Muhammed (peace be 
upon him) that the plant is full of medicinal value10, it 
gained immense popularity. 
Consequently, Kalonji has been extensively studied 
particularly in the Islamic world, which justifies its 
broad traditional therapeutic value. It was found to have 
antimicrobia111,12, anthelmintic13,14 
 wound healing' 5, 
antioxytocic16, antilipaemic17,18, antiplaque19, CNS 
depressant and analgesic20, antifertility2 , anticancer22-25, 
antiulcer26, post-coital contraceptive27, antiimplantation28, 
histamine release inhibitor29, antihypertensive6, 
antiinflammatory30, antidiabetic31 
 antispasmodic and renal 
protective properties32. 
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However, the plant has not been studied to provide 
the scientific basis for its use in asthma or diarrhoea. In this 
investigation, we provide evidence that the crude extract of 
Nigella sativa seeds contains calcium channel blocker(s), 
which may explain some of its traditional therapeutic uses, 
viz, diarrhoea, asthma and hypertension. Furthermore, 
activity-directed fractionation revealed that the activity 
reported in the crude extract might be due the presence of 
active principle(s) concentrated in the petroleum fraction 
and the further studies in collaboration of chemists are 
likely to yield interesting results. 
Material and Methods 
Drugs and Chemicals 
The following reference materials were obtained 
from the Sigma Chem. Co. St. Louis, USA: acetylcholine 
chloride, carbachol (carbamylcholine chloride), histamine 
phosphate and verapamil hydrochloride. 
Plant material, extraction and fractionation 
The seeds of Nigella sativa were purchased from the 
local market of Karachi, authenticated with the help of a 
botanist (Afzal Rizvi) at the Hamdard University, Karachi 
and the sample voucher has been submitted at the herbarium 
of the University. Seeds were ground to powder and soaked 
in 70% aqueous-methanol for three days and filtered. This 
procedure was repeated twice on the residue. All the 
filtrates were combined and concentrated under reduced 
pressure on a rotary evaporator below 40°C. The brownish 
black crude extract, yielding about 11% was coded as Ns.Cr. 
Ns.Cr was subjected to activity-directed 
fractionation by dissolving the crude extract in minimal 
amount of distilled water and successively extracted with 
different solvents of increasing polarity (Petroleum ether, 
Ethyl Acetate and Butanol) as shown in Scheme 1. The 
yields of different fractions were calculated as 1.98% of 
petroleum ether (Ns.Pet), 4.77% of ethyl acetate (Ns.EtAc), 
22.09% of butanol (Ns.But) and 71.16% of aqueous (Ns. 
Aq) fractions. 
Animals 
Rabbits (1.5-2.0 kg) and guinea pigs (500-600 g) of 
local breed and either sex, housed at the Animal House of 
the Aga Khan University, Karachi, were used for this study. 
Animals had free access to water but food was withdrawn 
24 hours prior to experiment in case of rabbit for the use of 
jejunum. Rabbits were sacrificed by blow on the back of the 
head and guinea pigs were sacrificed by cervical 
dislocation. 
Rabbit jejunum 
Spasmolytic action of the plant materials was 
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studied by using isolated rabbit jejunum as described 
previously33. Segments of jejunum (2 cm) were suspended 
in Tyrode's solution bubbled with a mixture of 95% oxygen 
and 5% carbon dioxide and maintained at 37°C. The 
composition of the Tyrode's solution in mM was: KC12.68, 
NaCI 136.9, MgCl2 1.05, NaHCO3 11.90, NaH2PO4 0.42, 
CaC12  1.8, and glucose 5.55. Intestinal responses were 
recorded isotonically using BioScience transducers and an 
oscillograph. Each tissue was allowed to equilibrate under 
the 1 g resting tension for at least 30 min before the addition 
of any drug. Under these experimental conditions, rabbit 
jejunum exhibited spontaneous, rhythmic contractions and 
allowed the test of relaxant (spasmolytic) activity directly 
without the use of an agonist. 
 
sol 
Ty.  
KC 
Na 
in( 
(D 
Ca 
th( 
to 
DI 
co 
  
 
 
Guinea-pig trachea 
Bronchodilator activity was studied by using guinea-
pig tracheal strip preparations as described previously34. 
Tracheal strip preparations were set up in Kreb's solution of 
the following composition in mM: NaCI, 118.0; KC1, 4.7; 
MgSO4, 1.64; KH2PO4, 1.2; D-glucose, 5.55; NaHCO3, 
25.0 and CaCl2, 2.5. A basal tension of 2g was applied to 
each tissue and the tissue was allowed to equilibrate at least 
for two hours. Under these experimental conditions, the 
tissue behaved as quiescent preparation. Carbachol, 
histamine and K+ were used as bronchoconstrictors, which 
produced sustained contractions and the relaxant activity of 
both crude extract and the petroleum fraction was assessed 
by adding the test materials in a cumulative fashion35. 
Calcium antagonist activity 
For the determination of calcium antagonist activity, 
both preparations were used and K+ was used to depolarize 
the preparations as described by Farre et a136. K+ (50 mM) 
was added to the tissue bath, which produced a sustained 
contraction. Plant extract was then added in a cumulative 
fashion to obtain concentration-dependent inhibitory 
responses. The relaxation of intestinal preparations, pre-
contracted with K+(50 mM) was expressed as percent of the 
control response mediated by K+. Contraction of smooth 
muscle induced by high K+(>30 mM) is known to be 
mediated, via influx of Ca** from extracellular fluid and the 
substance, which inhibits this contraction, is considered to 
act through blockade of voltage dependent slow calcium 
channels37. 
To confirm the calcium antagonist activity of test 
substances, rabbit jejunum was used, as it was relative quick 
in responding to drugs. The tissue was allowed to stabilize 
in normal Tyrode's solution, which was then replaced with 
Ca-H-free Tyrode's solution containing EDTA (0.1 mM) for 
30 min, in order to remove calcium from the tissues. This 
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solution was further replaced with K+-rich and Cat'-free 
Tyrode's solution, having the following composition in mM: 
KCI 50, NaCl 91.04, MgCl2 1.05, NaHCO3 11.90, 
NaH2PO4 0.42, glucose 5.55 and EDTA 0.1. Following an 
incubation period of 30 min, control dose-response curves 
(DRCs) of Ca++ were obtained. When the control DRCs of 
Ca++ were found superimposable (usually after two cycles), 
the tissue was pretreated with the test substance for 60 min 
to test the possible calcium channel blocking effect. The 
DRCs of ca++ were repeated in the presence of different 
concentrations of the test material. 
Results 
The Nigella sativa seeds have been traditionally used 
in a variety of diseases including diarrhea, asthma and 
hypertension. Its antihypertensive action has been 
confirmed in a recent study6, while there is no report 
available for the antidiarrhoeal and antiasthmatic activities. 
In view of its folkloric use in diarrhoea, the plant extract 
was tested for its possible spasmolytic activity in a 
spontaneously contracting gut preparation (rabbit jejunum). 
It caused a dose-dependent (0.1 - 3.0 mg/ml) suppression of 
spontaneous contractions thus showing spasmolytic activity 
(Figure 1). This figure also shows the dose-dependent (0.03 
- 0.3 mg/ml) spasmolytic effect of the petrolium ether 
fraction, which was found the most potent fraction as a 
result of activity-directed fractionation (Scheme 1). The 
butanol fraction was found least active and the ethyl acetate 
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Scheme 1.  
fraction occupying intermediate position in potency for 
spasmolytic activity. Aqueous fraction was found devoid of 
any spasmolytic activity, instead, mild spasmogenic activity 
was unmasked, which was atropine insensitive (data not 
shown). The spasmolytic activity has also been reported in 
an earlier study, which is of preliminary nature and the 
activity-directed fractionation has also not been carried out. 
To elucidate its possible mechanism involved in 
spasmolytic action, K+ (50 mM) was added to the tissue 
bath, which caused a sustained contraction. The plant 
extract was then added to the tissue bath to obtain dose-
dependent inhibitory responses and the combined data of 
different experiments is shown in Figure 2. The crude 
extract (Ns.Cr.) caused inhibition of K+-induced contraction 
in a similar concentration range (0.1-3.0 mg/ml). Similarly, 
Ns.Pet. fraction also caused a dose-dependent (0.03 - 0.3 
mg/ml) inhibition of K+-induced contractions being 
approximately 10 times more potent than the crude extract. 
The contractions induced by high K+ (>30 mM) 
are dependent upon entry of Ca++ into the cells through 
voltage-dependent calcium channels36 (Bolton, 1979) and a 
substance which inhibits K+-induced contractions is, 
therefore, considered to be a calcium channel blocker38. 
Thus, inhibition of high K+ (50 mM)-induced contractions 
of rabbit jejunum by the plant extract or its active fraction 
(Ns.Pet) may reflect restricted Ca++ entry via calcium 
channels. This hypothesis was further confirmed when 
pretreatment of the tissue with Ns.Cr or Ns.Pet caused a 
dose-dependent rightward shift in the dose-response curves 
of Cat', constructed in the Ca++ free solution (Figure 3). 
This figure also shows the dose-response curves of calcium 
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Figure 1. Tracings from a typical experiment, showing the effect of the aqueous-methanol extract 
of Nigella sative seeds (Ns.Cr) and its petrolium ether fraction (Ns.Pet) on spontaneous 
contractions of rabbit jejunum. Plant materials were administered by a cumulative method; the 
concentrations listed are final bath concentrations. 
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Figure 2. Comparison of the aqueous-methanol extract of Nigella sative seeds (Ns.Cr) and its 
petroleum ether fraction (Ns.Pet) for their inhibitory effect on K+-induced contractions in rabbit 
jejunum. The contractions induced by K+ (50 mM) were taken as control (100 % response). 
Ns.Pet elicited inhibitory response at doses about 10 times less than of the Ns. Cr. 
RABBir JEJUNUM 
.3 
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Figure 3. Comparison of the aqueous-methanol extract of Nigella sative seeds (Ns.Cr) and its 
petrolium ether fraction (Ns.Pet) and verapamil for their inhibitory effect on Ca++. An 
equilibrium period o30 min was used for each dose of the test materials before the re-
determination of Ca++ dose-response curves. Pretreatment of the tissue with plant materials 
caused displacement of Ca++ dose-response curves to the right, similar to that by verapamil. a 
known calcium antagonist. 
in the absence and presence of different concentrations of 
 
verapamil, a standard calcium channel blocker39. Both 
verapamil and the test materials caused dose-related 
displacement of the Ca++ curves. 
Discussion 
Calcium antagonists form an important therapeutic 
group, which is particularly employed in the treatment o 
different cardiovascular diseases40. The common 
characteristic of these drugs is their dose-dependent 
inhibition of the slow entry of calcium and their capacity for 
reversal of this effect by calcium ions38. The observed 
effect of the Ns.Cr and Ns.Pet fraction of the plant extract to 
inhibit Ca++ entry followed by being displaced with a high 
concentration of Ca++ confirms the presence of calcium 
antagonist(s), which is/are concentrated in the organic 
fraction. 
Interestingly calcium channel blockers (CCBs) are 
known to be effective in controlling diarrhoea through their 
spasmolytic action41 and the presence of CCBs in the 
Nigella sativa seeds may be responsible for its traditional 
use as an anti-diarrhoeal. The plant is also known to have 
anti-microbial activity against a wide range of 
organisms11,12 and this property may be a of added value, 
particularly in infective diarrhoea. 
Calcium channel blockers have been shown to be 
effective in asthma42,43. Based on its traditional use in 
asthma and the CCB activity reported in this study, the plant 
extract was studied for its possible bronchodilator action 
using isolated guinea-pig tracheal preparations 
Interestingly, the Ns.Cr. caused relaxation of trachea 
contractions induced by different bronchoconstrictors, such 
as histamine, carbachol and K+ (Figure 4), suggestive of 
non-specific bronchodilator action mediated possibly 
through calcium channel blockade. Consequently, the 
Ns.Pet was also studied for the possible CCB activity 
against K+-induced contractions in trachea. Ns. Pet, like in 
jejunum also inhibited K+-induced contractions in trachea, 
at doses approximately 10 times less than those found 
effective for crude extract (Figure 5). This suggests that the 
CCB constituent(s) is/are concentrated in this fraction and 
this activity may explain anti-asthmatic use of the plant in 
the traditional medicine, though possibility of other 
 
mechanisms also exists. 
The plant has also been shown to possess histamine 
release inhibitory activity29. Histamine is known to be the 
main mediator of bronchoconstriction44 and the agents, 
such as sodium chromoglycate, which inhibit the release of 
histamine are considered useful particularly as preventive 
measure in patients with chronic asthma. Such activity 
reported in this plant may be of additional benefit in asthma. 
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Figure 5. Comparison of the aqueous-methanol extract of Nigella sative seeds (Ns.Cr) and its 
petrolium ether fraction (Ns.Pet) for their inhibitory effect on K+-induced contractions in guinea- 
pig trachea. The contractions induced by K+ (50 ma.4) were taken as control (100% response). 
Ns.Pet elicited inhibitory response at doses about 10 times less than of the Ns. Cr. 
The plant has been traditionally used to treat 
hypertension and this effect was confirmed in a recent 
study6, which showed that the volatile oil of Nigella sativa 
seeds lowers blood pressure possibly through central 
Mechanism involving muscarinic and 5-HT receptor 
activation. Calcium antagonists are well known to be 
effective in treating hypertension4I and the presence of such 
constituent(s) in the crude extract (non-volatile part) 
reported in this study thus provide a complimentary 
mechanism of lowering blood pressure acting at the 
peripheral level. It is not uncommon that the 
antihypertensive drug therapy in modern medicine involves 
Vol. 51, No. 3, March, 2001 
Figure 4. Comparison of the inhibitory response of the aqueous-methanol extract of Nigella sative 
seeds (Ns.Cr) against contractions induced by histamine (Hist.), carbachol (CCh) and K+ in 
guie.a-pig trachea. Ns.Cr caused a dose-dependent inhibitory effect against all agonists used in a 
similar concentration range. 
GUINE-PIG TRACHEA  
use of multiple drugs acting at different sites39. 
These data indicate that the Nigella sativa seeds 
(Kalonji) contain calcium channel blocking constituent(s) 
thereby exhibiting spasmolytic and bronchodilator 
activities, which is/are concentrated in the petroleum ether 
fraction. The presence of CCB activity may partly explain 
the usefulness of the plant in different diseases, like 
diarrhoea, asthma and hypertension. Furthermore, presence 
of the multiple constituents acting mostly at different sites 
makes the plant versatile in its therapeutic success. 
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A Survival Analysis of Metastatic Breast Cancer in Pakistani Patients 
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Abstract 
Objective: To determine the overall survival of metastatic breast cancer in the Pakistani patients and compare 
it with published information. 
Method: The design was a retrospective analysis of metastatic breast cancer patients from breast cancer 
database. A total of 137 patient based information was available for review and analysis. 
Results: An overall median survival of 2.83 years was noted in metastatic breast cancer patients. 
Conclusion: This survival figure in this study compares favorably to those published in the literature (JPMA 51:120;2001). 
Introduction 
Metastatic breast cancer (MBC) or stage IV breast 
cancer is a major medical problem, which is not curable 
with the currently available therapies]. Besides medical 
issues a. significant amount of time, emotional energy and 
financial resources are required for its management. 
Therefore decision making is a medical challenge in such 
cases. The medical oncologist is helped in managing MBC 
by the knowledge of individual disease characteristics, 
which are known to be of prognostic significance in such a 
setting. Race and ethnic origin are recognized as significant 
prognostic factors for the outcome of many diseases 
120 
including breast cancer2
. In the United States, black 
populations do worse stage for stage, than the white women 
with breast cancer3,4
. Breast cancer tends to present at a 
more advanced stage in Pakistan than what is seen the West. 
Factors, which contribute to the advanced stage of 
presentation, include poor socioeconomic circumstances, 
social taboos and a general lack of education leading to 
poor! treatment choices. Additionally the biological nature 
of the disease in Pakistan may be different from that 
reported in the literatures. The factors, which may 
contribute to these differences, include race, ethnicity, 
nutritional factors and perhaps interfamily marriages. 
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